Second, we used a Jurkat T-cell line model to identify potential Tax and HBZ splicing targets, which were validated in primary cells isolated from two independent cohorts of HTLV-1 asymptomatic carriers and ATLL patients [6,8,55,56]. This evidence concerns the gene HBZ and adult T-cell leukemia/lymphoma.